All News

All News2017-04-25T19:59:37+00:00

Establishing Specialized CDMO Capabilities for the Production of Advanced Therapies

May 20, 2016

Establishing Specialized CDMO Capabilities for the Production of Advanced Therapies

To be successful, contract development and manufacturing organizations (CDMOs) must be forward thinking — constantly anticipating the future needs of potential customers and investing in state-of-the-art facilities, equipment, and technologies.

View Article

May 20th, 2016|Articles|

BioVectra – Hiring Practices – The Employment Journey on PEI

January 29, 2016

BioVectra – Hiring Practices – The Employment Journey on PEI

BioVectra is a custom manufacturer of pharmaceutical ingredients for pharma companies.  The company started when Dr. Regis Duffy, Dean of Science at UPEI, wanted to create summer employment for his students. Now, 45 years later, BioVectra is a wholly-owned subsidiary of a publicly-traded multinational pharmaceutical company with employees working primarily on PEI, as well as Nova Scotia and elsewhere.  “We have 260 talented people with diverse backgrounds in organic chemistry, polymer chemistry, biochemistry, molecular biology, and many fields of engineering, as well as specialists in manufacturing and quality assurance,” says Heather Delage, who has worked for BioVectra for 25 years.

View Article

January 29th, 2016|Articles|

BioVectra Announces Acquistion of Former Sunovion (Sepracor) Facility

June 23, 2014

BioVectra Announces Acquisition of Former Sunovion (Sepracor) Facility

BioVectra, a specialized cGMP manufacturer, and developer of pharmaceutical ingredients has announced today that it has agreed to purchase the previous Sepracor Canada Limited facility at Windsor, Nova Scotia, for an undisclosed sum.

View Article

June 23rd, 2014|News|

BioVectra Starts Construction to Expand Charlottetown Facility

June 11, 2014

BioVectra Starts Construction to Expand Charlottetown Facility

BioVectra, a specialized manufacturer and developer of pharmaceutical ingredients for the global marketplace, has commenced the expansion of one of its Prince Edward Island facilities, located at 11 Aviation Avenue, adjacent to the Charlottetown airport.

View Article

June 11th, 2014|News|

Risk Management in Financing of Capital Expansions

May 1, 2014

Risk Management in Financing of Capital Expansions

BioVectra Inc. is an eastern Canadian contract manufacturing organization (CMO) with expertise in both synthetic chemistry and biomanufacturing techniques. In recent years, it has obtained specialized knowledge in the production of highly potent small molecules from fermentation and functionalized methoxy-poly (ethylene glycol) products (MPEGs). The focus of BioVectra’s contract manufacturing business is the transfer and scale-up of processes for manufacturing its clients’ products under current good manufacturing practices (cGMPs) as appropriate for the clinical stage of each product.

View Article

May 1st, 2014|Articles|

BioVectra Spending $3.8 Million on Expansion

June 14, 2014

BioVectra Spending $3.8 Million on Expansion

An Island company that has been in business for more than 40 years is growing as BioVectra invests $3.8 million to expand one of its facilities in Charlottetown.

View Article

May 1st, 2014|Articles|

BioVectra Named Agent of Reagent Proteins’ Products

June 25, 2013

BioVectra Named Agent of Reagent Proteins’ Products

BioVectra announced today a new agreement naming BioVectra as a non-exclusive agent of Reagent Proteins in North America and Europe. BioVectra will provide its customers access to Reagent Proteins’ unique range of over 5,000 catalog protein products; as well as actively promoting Reagent Proteins’ capabilities through its agency network and directly to its key customers, including the potential for custom projects.

View Article

June 25th, 2013|News|